Showing results (21-30 of 91) with videos related to
Sort By:
Pageof 10
Journal of Mid-Life Health|July 15, 2017
Health-related Factors Associated with Adherence to Breast Cancer ScreeningJoke Schoofs, Katrien Krijger, Jan Vandevoorde, et al.Open Access Macedonian Journal of Medical Sciences|November 21, 2018
The Quality of EBM Sources Perceived By Belgian Family PhysiciansLaurence de Fernelmont, Sven Van Laere, Dirk DevroeyInternational Journal of Cardiology|May 11, 2005
The benefit of fibrates in the treatment of 'bad HDL-C responders to statins'Dirk Devroey, Brigitte Velkeniers, William Duquet, et al.Journal of Immigrant and Minority Health|April 6, 2019
Five Years Later: The Impact of a Hunger Strike on Undocumented Migrant Workers in BrusselsRita Vanobberghen, Fred Louckx, Dirk Devroey, et al.Acta Cardiologica|July 9, 2003
Serum lipid comparison in patients treated by statins or fibrates: existence of bad HDL-C responders to statinsDirk Devroey, Brigitte Velkeniers, William Duquet, et al.Archivio Italiano Di Urologia, Andrologia : Organo Ufficiale [Di] Societa Italiana Di Ecografia Urologica E Nefrologica|October 14, 2014
Diagnosis and treatment of participants of support groups for hypersexual disorderEls Tierens, Johan Vansintejan, Jan Vandevoorde, et al.Journal of Public Health (Oxford, England)|March 27, 2004
An 8 year nationwide prospective registration of non-consented HIV testing in BelgiumViviane Van Casteren, Dirk Devroey, André Sasse, et al.Systematic Reviews|February 22, 2014
Do randomized clinical trials with inadequate blinding report enhanced placebo effects for intervention groups and nocebo effects for placebo groups?Frederik Feys, Geertruida E Bekkering, Kavita Singh, et al.Systematic Reviews|November 16, 2012
Do randomized clinical trials with inadequate blinding report enhanced placebo effects for intervention groups and nocebo effects for placebo groups? A protocol for a meta-epidemiological study of PDE-5 inhibitorsFrederik Feys, Geertruida E Bekkering, Kavita Singh, et al.Cardiology|April 23, 2004
A review of the treatment guidelines on the management of low levels of high-density lipoprotein cholesterolDirk Devroey, Karolien Vantomme, Willem Betz, et al.Pageof 10